Effects of an ACWR-Guided Load Management Intervention on Time-Loss Injury Incidence in Chinese Elite Youth Footballers: A Cluster Randomised Controlled Trial (ACWR Injury)

July 22, 2026 updated by: Jun Li, Xinyang Agriculture and Forestry University
This cluster-randomised controlled trial aims to evaluate whether a multi-component load management intervention-incorporating real-time acute:chronic workload ratio (ACWR) feedback, automated alerts, coach education, and structured load adjustment protocols-reduces time-loss injury incidence in Chinese elite mixed-gender adolescent football players compared with routine training practices.

Study Overview

Status

Not yet recruiting

Detailed Description

Background: Injury prevention in elite youth football is a public health and performance priority. Approximately two-thirds of players sustain at least one time-loss injury annually, with lower extremity injuries predominating. The acute:chronic workload ratio (ACWR) is widely used in sport science as a practical decision-support tool, yet experimental evidence for its effectiveness in reducing injury incidence remains limited and conflicting, particularly in Asian adolescent populations.

Objectives: This cluster-randomised controlled trial evaluates whether a multi-component ACWR-guided load management intervention reduces time-loss injury incidence in Chinese elite youth football players compared with routine practice.

Study Design: A prospective, two-arm, parallel-group, cluster-randomised controlled trial with 1:1 allocation, stratified by age group (U15/U17/U19).

Participants: Twenty-eight elite youth football teams (U15-U19, n=774, 45.2% female) from 28 academies in Henan Province.

Intervention: The intervention comprises real-time ACWR feedback, automated alerts for values outside the 0.8-1.3 range, coach education workshops, and structured load-adjustment protocols. Control teams follow routine practice without ACWR-derived feedback.

Primary Outcome: Time-loss injury incidence rate per 1000 athlete-exposure hours.

Secondary Outcomes: (1) Severe injury incidence (≥28 days lost); (2) Injury burden (days lost per 1000 h); (3) Proportion of lower-extremity injuries; (4) Proportion of non-contact injuries.

Sample Size: 28 teams (14 per arm) with 774 players (median 27 per team, range 22-31), providing 80% power to detect a 25% reduction in injury incidence (IRR=0.75) with α=0.05 and ICC=0.05.

Statistical Analysis: Mixed-effects Poisson regression with ICC adjustment, Fine-Gray competing risk models, shared frailty Cox models, Kaplan-Meier survival analysis, and E-value sensitivity analysis.

Ethics: The study protocol was approved by the Xinyang Agriculture and Forestry University Ethics Committee (XYAFUAE2024021). Written informed consent was obtained from all participants and their parents/legal guardians.

Study Type

Interventional

Enrollment (Estimated)

847

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 13-19 years Member of a participating U15, U17, or U19 team No injury precluding full participation at enrolment Provided written informed consent (parental consent for minors)

Exclusion Criteria:

  • Injury precluding full participation at enrolment Failure to provide informed consent Age outside 13-19 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ACWR Intervention vs Control Trial
Coaches in this group will plan and adjust all training sessions based on published Acute:Chronic Workload Ratio (ACWR) load management principles. Player training load data will be monitored using a commercially available athlete management system. The intervention will be implemented for the duration of the complete season. The ACWR will be used to guide training prescription, with the goal of managing the players' acute and chronic workloads to reduce injury risk

Intervention teams implement a structured ACWR-guided load management protocol for the entire season. The protocol comprises four components:

Component 1 - Load Monitoring: After each training session and match, players rate perceived exertion on the Borg CR-10 scale. Session-RPE (sRPE) is calculated as duration (minutes) × RPE score. Data are recorded using a dedicated mobile application (CoachMe v3.2). Research staff provide technical support and weekly reminders.

Component 2 - Weekly ACWR Reports: The research team generates weekly ACWR reports for each player. Reports are emailed to head coaches each Monday morning, covering the preceding week's data.

Component 3-Automated Alerts and Load-Adjustment Recommendations: Coaches receive automated alerts when a player's ACWR falls below 0.8 or exceeds 1.3. When ACWR < 0.8, a progressive increase in training load (10-20% weekly) is suggested. When ACWR > 1.3, coaches are instructed to implement a 10-20% load reduction at the next session,

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time-loss injury incidence rate per 1000 athlete-exposure hours.
Time Frame: From enrolment to the end of the 10-month competitive season
Definition: Consistent with the football injury consensus statement, a time-loss injury is defined as any physical impairment sustained during structured football training or competitive matches that prevents a player from full participation in subsequent training sessions or matches. Injuries occurring outside football activities are not recorded.
From enrolment to the end of the 10-month competitive season

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Study Registration Dates

First Submitted

July 20, 2026

First Submitted That Met QC Criteria

July 22, 2026

First Posted (Actual)

July 27, 2026

Study Record Updates

Last Update Posted (Actual)

July 27, 2026

Last Update Submitted That Met QC Criteria

July 22, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All of the individual participant data collected during the trial, after deidentification. This will include, but is not limited to: baseline demographic and anthropometric data, training load metrics (e.g., acute:chronic workload ratio [ACWR] and its components), time-loss injury incidence and severity data, and exposure hours.

Additional documents to be made available: Study Protocol, Statistical Analysis Plan (SAP), and Informed Consent Form (ICF).

Time frame: Data will be available beginning 9 months and ending 36 months following publication of the primary results.

Access criteria: Data will be made available to researchers who provide a methodologically sound proposal for the purpose of achieving the aims in the approved proposal. Proposals should be directed to the Principal Investigator. To gain access, data requesters will need to sign a data access agreement

IPD Sharing Time Frame

Beginning 9 months and ending 36 months following article publication.

IPD Sharing Access Criteria

Data will be shared with researchers who provide a methodologically sound proposal, to achieve the aims in the approved proposal. Proposals should be directed to the Principal Investigator (PI). To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe